James Kihara, Principal Accounting Officer at Acadia Pharmaceuticals, sold ACAD on Jun 26, 2026
Data as of Oct 27
▼ SELL$298K11,421 shares at $26.08James Kihara Principal Accounting OfficerACAD Acadia Pharmaceuticals Inc
- Traded
- Jun 26, 2026
- Disclosed
- Jun 29, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ACAD since disclosure
−20.0%
after the sale
Similar stocks (XLV) since disclosure
+11.5%
XLV — its sector index fund
Change in closing price from Jun 29, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.